[go: up one dir, main page]

WO2002067955A3 - A process for the manufacture of a herbal composition comprising a matrine - Google Patents

A process for the manufacture of a herbal composition comprising a matrine Download PDF

Info

Publication number
WO2002067955A3
WO2002067955A3 PCT/EP2002/002350 EP0202350W WO02067955A3 WO 2002067955 A3 WO2002067955 A3 WO 2002067955A3 EP 0202350 W EP0202350 W EP 0202350W WO 02067955 A3 WO02067955 A3 WO 02067955A3
Authority
WO
WIPO (PCT)
Prior art keywords
herbal
plant material
herbal composition
manufacture
matrine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/002350
Other languages
French (fr)
Other versions
WO2002067955A2 (en
Inventor
John Wah Tze
Peizhong Lin
Stephen Lam
Joseph Tai
Frisi Hobbe Smit
Helvoort Adrianus Lambertu Van
Robert Johan Hageman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Global Cancer Strategies Ltd
Original Assignee
Global Cancer Strategies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Global Cancer Strategies Ltd filed Critical Global Cancer Strategies Ltd
Priority to JP2002567321A priority Critical patent/JP2004529885A/en
Priority to HK04104308.5A priority patent/HK1061203B/en
Priority to DE60206474T priority patent/DE60206474T2/en
Priority to AT02702393T priority patent/ATE305794T1/en
Priority to US10/468,894 priority patent/US20040170704A1/en
Priority to AU2002235930A priority patent/AU2002235930A1/en
Priority to EP02702393A priority patent/EP1370271B1/en
Publication of WO2002067955A2 publication Critical patent/WO2002067955A2/en
Publication of WO2002067955A3 publication Critical patent/WO2002067955A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536—Prunella or Brunella (selfheal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Fertilizers (AREA)

Abstract

The present invention is concerned with a process for the manufacture of a herbal composition, said process comprising: a. subjecting a matrine containing plant material, in the absence of a plant material derived from the species Dictamnus, to an extraction with an aqueous solvent, optionally followed by a concentration step, to produce a herbal extract I; b. subjecting a plant material derived from the species Dictamnus, to an extraction with an aqueous solvent, optionally followed by a concentration step, to produce a herbal extract II; c. mixing the herbal extracts I and II; d. provided the resulting mixture contains a significant amount of water, drying the mixture to a water content of less than 6 wt. %. The herbal composition according to the present invention may advantageously be used in a method of treating or preventing cancer, H. pylori infections, chronic inflammatory conditions, cardiovascular diseases or cerebral vascular diseases in mammals.
PCT/EP2002/002350 2001-02-26 2002-02-26 A process for the manufacture of a herbal composition comprising a matrine Ceased WO2002067955A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP2002567321A JP2004529885A (en) 2001-02-26 2002-02-26 Method for producing herbal composition
HK04104308.5A HK1061203B (en) 2001-02-26 2002-02-26 A process for the manufacture of a herbal composition comprising a matrine
DE60206474T DE60206474T2 (en) 2001-02-26 2002-02-26 PROCESS FOR THE PRODUCTION OF A MATRINE-CONTAINING PLANT EXTRACT
AT02702393T ATE305794T1 (en) 2001-02-26 2002-02-26 PROCESS FOR PRODUCING A PLANT EXTRACT CONTAINING MATRINE
US10/468,894 US20040170704A1 (en) 2001-02-26 2002-02-26 Process for the manufacture of a herbal composition
AU2002235930A AU2002235930A1 (en) 2001-02-26 2002-02-26 A process for the manufacture of a herbal composition comprising a matrine
EP02702393A EP1370271B1 (en) 2001-02-26 2002-02-26 A process for the manufacture of a herbal composition comprising a matrine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/793,251 US20030099725A1 (en) 2001-02-26 2001-02-26 Herbal compositions useful as chemopreventive and therapeutic agents and methods of manufacturing same
US09/793,251 2001-02-26

Publications (2)

Publication Number Publication Date
WO2002067955A2 WO2002067955A2 (en) 2002-09-06
WO2002067955A3 true WO2002067955A3 (en) 2002-11-07

Family

ID=25159475

Family Applications (4)

Application Number Title Priority Date Filing Date
PCT/CA2002/000204 Ceased WO2002067960A1 (en) 2001-02-26 2002-02-26 Herbal compositions useful as chemopreventive and therapeutic agents
PCT/CA2002/000222 Ceased WO2002067961A2 (en) 2001-02-26 2002-02-26 Therapeutic uses of herbal compositions
PCT/EP2002/002350 Ceased WO2002067955A2 (en) 2001-02-26 2002-02-26 A process for the manufacture of a herbal composition comprising a matrine
PCT/EP2002/002351 Ceased WO2002072120A1 (en) 2001-02-26 2002-02-26 Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PCT/CA2002/000204 Ceased WO2002067960A1 (en) 2001-02-26 2002-02-26 Herbal compositions useful as chemopreventive and therapeutic agents
PCT/CA2002/000222 Ceased WO2002067961A2 (en) 2001-02-26 2002-02-26 Therapeutic uses of herbal compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/002351 Ceased WO2002072120A1 (en) 2001-02-26 2002-02-26 Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases

Country Status (10)

Country Link
US (5) US20030099725A1 (en)
EP (4) EP1370274A1 (en)
JP (1) JP2004529885A (en)
CN (1) CN1585647A (en)
AT (3) ATE304368T1 (en)
AU (2) AU2002235930A1 (en)
CA (1) CA2439301A1 (en)
DE (3) DE60227068D1 (en)
DK (1) DK1370271T3 (en)
WO (4) WO2002067960A1 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60215060T2 (en) * 2002-12-13 2007-04-05 Gobind Prasad Dubey HERB PREPARATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND NEUROLOGICAL DISEASES
US8668908B2 (en) * 2002-12-31 2014-03-11 National Yang-Ming University Method for alleviating chemotherapy side effects using extract of Dioscorea sp
US20060068036A1 (en) 2002-12-31 2006-03-30 National Yang-Ming University Extract of Dioscorea sp. and the medical uses thereof
GB0317020D0 (en) * 2003-07-21 2003-08-27 Sahajanand Biotech Private Ltd Herbo-mineral formulation for refractory leukemias and lymphomas
US20050025823A1 (en) * 2003-07-29 2005-02-03 Fong Andy A.T. Methods of use of herbal compositions
US20060008540A1 (en) * 2004-07-08 2006-01-12 Rulin Xiu Herbal compositions comprising portaluca
US20060024391A1 (en) * 2004-07-30 2006-02-02 Lak Zarahmehran S Dietary nutritional suppliments for persons smoking tobacco products
US7368133B2 (en) * 2004-08-23 2008-05-06 Yu Ching Wu Medicinal drug and methods of manufacturing the same
US7384657B2 (en) * 2004-10-14 2008-06-10 Jeffrey Young Composition of natural herb extract for treating cardiovascular disease and its method of preparation thereof
WO2006066354A1 (en) * 2004-12-24 2006-06-29 Dolphst Pty Ltd Formula ions and treatments for well-being
WO2007012335A1 (en) * 2005-07-26 2007-02-01 Djamila Souiki Treatment for all types of cancer, cysts, fibromas, infections, inflammations, anxiety, migraines, hormonal imbalance, ulcers, asthma, crohn's disease, eczema, psoriasis, rheumatism, acne
CN100431581C (en) * 2006-01-20 2008-11-12 丽珠医药集团股份有限公司 Traditional Chinese medicine composition for treating fowl influenza, its preparation method and uses
US20070202215A1 (en) * 2006-02-28 2007-08-30 Zahramehran Salari Lak Dietary nutritional supplements for persons consuming alcohol products
JPWO2007132893A1 (en) * 2006-05-17 2009-09-24 アークレイ株式会社 MCP-1 expression inhibitor, inflammatory disease ameliorating agent, pharmaceutical, supplement, food, beverage and food additive using the same
US20090011060A1 (en) * 2007-07-06 2009-01-08 Peter Koepke Campsiandra angustifolia extract and methods of extracting and using such extract
US7879369B2 (en) 2007-09-18 2011-02-01 Selvamedica, Llc Combretum laurifolium Mart. extract and methods of extracting and using such extract
DE202008011721U1 (en) * 2008-09-03 2008-12-24 American Phoenix Biotech Inc., Hacienda Heights Herbal composition for the treatment of cancer
KR101103426B1 (en) 2009-04-10 2012-01-09 영남대학교 산학협력단 Pharmaceutical composition for the treatment of inflammatory bowel disease containing molugin or molugin derivative as an active ingredient
US8535739B2 (en) * 2010-01-28 2013-09-17 George Lowe Sparkle essence system
KR20120080674A (en) * 2011-01-08 2012-07-18 주식회사한국전통의학연구소 Composition for treatment of leukemia and functional food comprising extract of circii radix
CN102091049B (en) * 2011-01-17 2015-12-02 广东东阳光药业有限公司 Matrine dispersible tablet and preparation process thereof
CN103127057A (en) * 2011-11-25 2013-06-05 复旦大学 Application of fraxinellone in preparing of antineoplastic medicines
CN102532147B (en) * 2011-12-30 2014-05-21 山东省分析测试中心 Preparation method of high purity dictamnine monomer
CN102641454B (en) * 2012-05-22 2014-01-01 江苏省中医药研究院 Traditional Chinese medicine composition for treating chronic atrophic gastritis
CN103630630B (en) * 2013-12-16 2014-11-19 广西大学 A kind of content determination method of matrine in mountain bean root medicinal material
CN104887834A (en) * 2014-03-04 2015-09-09 苏州益福康材料科技有限公司 Matrine containing composition for treatment or prevention of mammal cancer and other diseases
CN104887684A (en) * 2014-03-07 2015-09-09 复旦大学 Application of yamogenin in preparation of antitumor drugs
CN105250743A (en) * 2015-09-17 2016-01-20 连艳芬 Traditional Chinese medicine for treating lung cancer
CN105769880B (en) * 2016-03-09 2018-05-15 广东省中医院 Application of the obakunone in the medicine of prevention injury of lungs and pulmonary fibrosis is prepared
CN106526057B (en) * 2016-09-22 2017-12-05 广东东阳光药业有限公司 A kind of thin-layer chromatographic analysis method for detecting flavones ingredient in serpentgrass
WO2019232146A1 (en) * 2018-06-01 2019-12-05 Yale University Compositions and methods for treating steroid hormone-related diseases or disorders
CN108815435A (en) * 2018-08-31 2018-11-16 陕西石宇药业有限公司 A kind of preparation method of the Chinese medicine composition for treating pruritus dermatopathy and its preparation
CN110960668A (en) * 2018-09-28 2020-04-07 上海市浦东新区浦南医院 Composition for preventing and treating liver diseases and application thereof
KR102236022B1 (en) * 2019-06-24 2021-04-05 계명대학교 산학협력단 Composition for skin whitening or improving winkle comprising sonchus brachyotus extract
CN110354010A (en) * 2019-07-24 2019-10-22 石家庄市中医院 It is a kind of to have effects that the mouthwash of anti-helicobacter pylori
CN110297060B (en) * 2019-07-25 2021-09-17 广西中医药大学 Fingerprint detection method and fingerprint thereof for ixeris sonchifolia medicinal materials
KR102093073B1 (en) * 2019-08-30 2020-03-24 국립해양생물자원관 Antiinflammatory composition comprising extracts of sonchus brachyotus
WO2021188295A1 (en) * 2020-03-17 2021-09-23 Epidarus Therapeutics, Llc Compositions for inhibiting degradation of hyaluronic acid and methods of use thereof
CN111317734A (en) * 2020-03-27 2020-06-23 广州医科大学附属第二医院 Wnt signaling pathway inhibitors and applications
KR102456184B1 (en) * 2020-09-21 2022-10-18 국립해양생물자원관 Composition for preventing or treating nasal polyp comprising extract of sonchus brachyotus
CN114246868B (en) * 2021-12-24 2023-06-06 中国人民解放军军事科学院军事医学研究院 An inhibitor of urinary tract infection pathogen uropathogenic Escherichia coli
CN114271144A (en) * 2021-12-31 2022-04-05 张宇希 A kind of method for planting Radix isatidis under a fir tree
CN114259488A (en) * 2022-01-27 2022-04-01 杭州师范大学 Application of traditional Chinese medicine molecule fraxinellone in preparation of medicine for treating glioma
CN115192571A (en) * 2022-07-11 2022-10-18 中国人民解放军总医院第五医学中心 Application of compound Rutaevin in the preparation of medicaments for the treatment of gastric cancer
CN116115631B (en) * 2022-12-09 2025-06-17 中南民族大学 External use bletilla striata polysaccharide preparation for preventing and treating eczema and itching, and preparation method and application thereof
CN115778888B (en) * 2023-02-10 2023-04-28 云南云科特色植物提取实验室有限公司 Preparation method of bletilla striata extract, product and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001003749A1 (en) * 1999-07-13 2001-01-18 Deuk Hun Ahn Herb medicine composition to be contained in sanitary materials for infants

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU83173A1 (en) * 1981-02-27 1981-06-05 Oreal NOVEL COSMETIC COMPOSITIONS FOR THE TREATMENT OF HAIR AND SKIN CONTAINING POWDER RESULTING FROM THE SPRAYING OF AT LEAST ONE PLANT AND A COHESION AGENT
GB2226494B (en) * 1988-07-20 1991-10-09 Poon Theodore Man Photosynthesis in men's blood to cure cancer-part 2 phmd(cancer)
CN1047975A (en) * 1989-06-13 1990-12-26 李晨芙 A kind of compound method of anticancer agent
US5411733A (en) * 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
EP0665017A1 (en) * 1993-12-30 1995-08-02 Henne, Kurt Medicament for the prophylaxis and treatment of tumors
CN1124092A (en) * 1994-12-10 1996-06-12 王跃进 Flour good for health
CN1125591A (en) * 1994-12-28 1996-07-03 刘继先 Stomach tranquilizer
JPH0912451A (en) * 1995-06-30 1997-01-14 Terumo Corp Anti-helicobacter pyrolii agent
CN1159340A (en) * 1996-03-11 1997-09-17 李城林 Prescription of anticancer and tumor-inhibiting medicine and its preparing process
CN1175458A (en) * 1997-09-05 1998-03-11 张玉杰 Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases
KR100239879B1 (en) * 1997-11-05 2000-02-01 김상조 Herbal medicine for preventing and treating liver cancer
EP1077715B1 (en) * 1998-05-16 2006-03-29 Mogam Biotechnology Research Institute Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process
CN1094367C (en) * 1999-02-10 2002-11-20 徐守宏 Linjunsha medicine
CN1324657A (en) * 1999-09-29 2001-12-05 马纯熙 Chinese medicine prepn. for treating cardiac and cerebral vascular diseases and its prepn. process
DE10031651A1 (en) * 2000-06-29 2002-01-17 Schwabe Willmar Gmbh & Co Extracts from Sophora species, process for their preparation and use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001003749A1 (en) * 1999-07-13 2001-01-18 Deuk Hun Ahn Herb medicine composition to be contained in sanitary materials for infants

Also Published As

Publication number Publication date
US20040192579A1 (en) 2004-09-30
DE60206137D1 (en) 2005-10-20
EP1370271A2 (en) 2003-12-17
DE60206137T2 (en) 2006-07-27
US20060165816A1 (en) 2006-07-27
JP2004529885A (en) 2004-09-30
ATE304368T1 (en) 2005-09-15
AU2002235930A1 (en) 2002-09-12
WO2002067960A1 (en) 2002-09-06
AU2002231544A1 (en) 2002-09-12
WO2002067955A2 (en) 2002-09-06
US20040170704A1 (en) 2004-09-02
DK1370271T3 (en) 2006-02-20
ATE397936T1 (en) 2008-07-15
HK1061203A1 (en) 2004-09-10
EP1370274A1 (en) 2003-12-17
ATE305794T1 (en) 2005-10-15
DE60206474D1 (en) 2005-11-10
CN1585647A (en) 2005-02-23
DE60206474T2 (en) 2006-07-13
CA2439301A1 (en) 2002-09-19
WO2002067961A3 (en) 2003-05-15
US20030099725A1 (en) 2003-05-29
EP1392334B1 (en) 2008-06-11
DE60227068D1 (en) 2008-07-24
WO2002067961A2 (en) 2002-09-06
WO2002072120A1 (en) 2002-09-19
EP1370271B1 (en) 2005-10-05
EP1363651A1 (en) 2003-11-26
HK1060694A1 (en) 2004-08-20
EP1363651B1 (en) 2005-09-14
EP1392334A2 (en) 2004-03-03
US20050025841A1 (en) 2005-02-03

Similar Documents

Publication Publication Date Title
WO2002067955A3 (en) A process for the manufacture of a herbal composition comprising a matrine
M’rabet et al. Profiling of phenolic compounds and antioxidant activity of Melia azedarach L. leaves and fruits at two stages of maturity
KR910004206A (en) Method for preparing high content anthocyanoxide extract
PT1001797E (en) SOYBEAN EXTRACT, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITION
CA2421761A1 (en) Crab apple fruit polyphenol and production process thereof
CN103478895A (en) Method for preventing browning reaction caused by improper tobacco leaf curing
RU2000115345A (en) METHOD OF PRODUCTION PHYTOCHAYA, PHYTOCHAY
ZA986161B (en) Treatment of formaldehyde-containing mixtures
KR101802097B1 (en) Harvest Time detecting method of Orostachys japonicus using phenolic acid profile
RU2008101384A (en) EXTRACT Salix, ITS USE AND COMPOSITIONS ITS CONTAINING
CN1228432A (en) Method for extracting material containing raw anthocyanidin from ginkgo leaf by supercritical carbon dioxide
DE59203258D1 (en) Process for the production of Rhizoma Petasitidis extracts with carbon dioxide.
CN101143816A (en) Ultrasonic Extraction of Ferulic Acid in Angelica
AU4657699A (en) Extraction method, pharmaceutical composition and a cosmetic composition
DE50103561D1 (en) METHOD FOR PRODUCING PHYLLANTHUS EXTRACTS
CN1125709C (en) Deodorizing process method for guiweimao wood
WO2021243856A1 (en) Method for extracting myrica rubra leaf proanthocyanidins
Wafa Antioxidant and anti-inflammatory activities valorisation of methanol extract of two Fabaceae (Genesta pseudo-pilosa and Spartium junceum L) growth in East of Algeria
MD1530G2 (en) Process for oak extract production for acceleration of wine and alcoholic drinks maturation
CN110538212A (en) Preparation method for extracting total flavonoids from eucommia leaves
DE69804306D1 (en) METHOD FOR PRODUCING A COMPOSITION THAT CAN BE USED FOR PRODUCING PLUGS, COMPOSITION AND A PLASTIC CONTAINING SUCH A COMPOSITION
KR950016772A (en) Use as an anti-inflammatory analgesic of water extract of cheonhwamin
JPS56154975A (en) Preparation of concentrated soup stock
Nesterova et al. Identification of phloretin and phlorizine in the fruits of east apple (Malus Orientalis Uglitzk. ex Jus) and assessment of the quantitative content of substances of phenolic nature
WO2004060267A3 (en) A process for producing enriched fractions containing up to 100% of bacoside a and bacoside b

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002567321

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002702393

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002702393

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10468894

Country of ref document: US

WWG Wipo information: grant in national office

Ref document number: 2002702393

Country of ref document: EP